CHINESE PHARMA COMPANIES EYE INVESTMENTS IN SUB-SAHARAN AFRICA, BUT THE GOING IS TOUGH
January 1st, 2016
China pharmaceutical industry investors want to help sub-Saharan African countries meet growing domestic demand for medicine in return for tax breaks and private-public partnership initiatives. But there are difficulties – including product quality and standards issues that impede the flow of Chinese Yuan into African pharma production. Indeed, converting financial resources into operating manufacturing plants can be a slow and troublesome process in the region’s less than optimal corporate governance climate.
Nigeria, now Africa’s largest economy, with a ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.